EVH - Evolent Health Inc Stock Price, Fair Value and News

$23.28+0.09 (+0.39%)

Delayed as of 22 Oct 2024, 09:51 am ET

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

EVH Price Action

Last 7 days

-14.4%

Last 30 days

-25.2%

Last 90 days

11.5%

Trailing 12 Months

-13.6%

EVH RSI Chart

EVH Valuation

Market Cap

2.7B

Price/Earnings (Trailing)

-36.24

Price/Sales (Trailing)

1.15

EV/EBITDA

117.95

Price/Free Cashflow

15.3

EVH Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

EVH Fundamentals

EVH Revenue

Revenue (TTM)

2.4B

Rev. Growth (Yr)

37.94%

Rev. Growth (Qtr)

1.17%

EVH Earnings

Earnings (TTM)

-74.4M

Earnings Growth (Yr)

104.65%

Earnings Growth (Qtr)

109.24%

EVH Profitability

Operating Margin

18.57%

EBT Margin

-4.01%

Return on Equity

-7.06%

Return on Assets

-3.01%

Free Cashflow Yield

6.53%

EVH Investor Care

Shares Dilution (1Y)

2.69%

Diluted EPS (TTM)

-0.94

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	2.2B	2.4B	0	0
2023	1.5B	1.6B	1.8B	2.0B
2022	989.9M	1.1B	1.2B	1.4B
2021	918.5M	923.2M	906.1M	908.0M
2020	869.9M	895.2M	914.6M	924.6M
2019	685.1M	732.8M	803.0M	846.4M
2018	468.4M	505.7M	547.7M	627.1M
2017	311.0M	361.5M	409.2M	434.9M
2016	146.3M	192.4M	212.2M	254.2M
2015	0	49.4M	73.1M	96.9M
2013	0	0	0	25.7M

Get all data in R, Python etc through our Historical Stock Data APIs

About Evolent Health Inc

Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, offers clinical and administrative solutions to payers and providers in the United States. The company operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology, cardiology, and musculoskeletal markets; physician-oriented total cost of care solutions; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.

CEO	Mr. Seth Barrie Blackley
WEBSITE	evolenthealth.com
SECTOR	Healthcare
INDUSTRY	Health Information Services
EMPLOYEES	5100

Evolent Health Inc Frequently Asked Questions

What is the ticker symbol for Evolent Health Inc? What does EVH stand for in stocks?

EVH is the stock ticker symbol of Evolent Health Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Evolent Health Inc (EVH)?

As of Mon Oct 21 2024, market cap of Evolent Health Inc is 2.7 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of EVH stock?

You can check EVH's fair value in chart for subscribers.

Is Evolent Health Inc a good stock to buy?

The fair value guage provides a quick view whether EVH is over valued or under valued. Whether Evolent Health Inc is cheap or expensive depends on the assumptions which impact Evolent Health Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for EVH.

What is Evolent Health Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Oct 21 2024, EVH's PE ratio (Price to Earnings) is -36.24 and Price to Sales (PS) ratio is 1.15. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. EVH PE ratio will change depending on the future growth rate expectations of investors.